Vagistat-1 (tioconazole) ointment is now approved for OTC use

    Vagistat-1 (tioconazole) ointment is now approved for OTC use. It's the first SINGLE-dose OTC treatment for vaginal yeast infections.

    Vagistat-1 is comparable to using Terazol 3 (terconazole) or Monistat 7 (miconazole).

    Tioconazole levels persist for 3 to 5 days after one dose.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote